NCT00319813

Brief Summary

A Cross sectional observational Quality Assurance Project in General Practice to COPD Diagnosis and Treatment

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2006

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 19, 2006

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

April 20, 2006

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 27, 2006

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 5, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 5, 2007

Completed
Last Updated

December 7, 2023

Status Verified

November 1, 2023

Enrollment Period

1.4 years

First QC Date

April 20, 2006

Last Update Submit

November 30, 2023

Conditions

Pulmonary Disease, Chronic Obstructive

Outcome Measures

Primary Outcomes (3)

  • To optimise the diagnosis and treatment of COPD via a quality assurance project

    Up to 1.2 years

  • Increase the knowledge and use of diagnostic tools and treatment amongst PCPs

    Up to 1.2 years

  • To focus on implementation of national guidelines for diagnosis and treatment of COPD

    Up to 1.2 years

Interventions

EducationBEHAVIORAL

Eligibility Criteria

Age35 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • COPD patients over 35 years of age
  • More than two annual renewals with the following group of inhalation preparations: Anticholinergic, beta-2 antagonists, steroids or a combination of these

You may not qualify if:

  • Asthma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

Educational Status

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Socioeconomic FactorsPopulation Characteristics

Study Officials

  • Boehringer Ingelheim Study Coordinator

    B.I. Denmark A/S

    STUDY CHAIR

Study Design

Study Type
observational
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 20, 2006

First Posted

April 27, 2006

Study Start

April 19, 2006

Primary Completion

September 5, 2007

Study Completion

September 5, 2007

Last Updated

December 7, 2023

Record last verified: 2023-11